Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. ETF
  3. BSX
BSX logo

BSX

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewTechnicalNews
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

BSX News

Boston Scientific Schedules Q1 2026 Earnings Call

13h agoPRnewswire

BOSTON SCIENTIFIC STOCK FALLS 5.6% FOLLOWING RAYMOND JAMES UPGRADE TO OUTPERFORM FROM STRONG BUY

12h agomoomoo

Boston Scientific Launches New Irrigation Management System

14h agoNewsfilter

BOSTON SCIENTIFIC CORP: RAYMOND JAMES LOWERS RATING TO OUTPERFORM FROM STRONG BUY; REDUCES TARGET PRICE TO $88 FROM $97

15h agomoomoo

Boston Scientific Launches New Irrigation Management System for Urology

15h agoPRnewswire

Boston Scientific Class Action Lawsuit Announcement

15h agoGlobenewswire

Boston Scientific Faces Class Action Lawsuit Over Securities Violations

1d agoGlobenewswire

Faruqi & Faruqi Encourages Boston Scientific Investors to Reach Out

1d agoPRnewswire

Boston Scientific Reports Positive EKOS System Clinical Trial Results

2d agoNASDAQ.COM

Boston Scientific's CHAMPION-AF Trial Achieves Success

2d agoNASDAQ.COM

WATCHMAN FLX Device Clinical Trial Achieves Success

2d agoPRnewswire

WATCHMAN FLX Device Clinical Trial Achieves Success

2d agoNewsfilter

Boston Scientific's EKOS Device Shows Positive Clinical Trial Results

2d agoNewsfilter

EKOS System Shows Superiority in Treating Acute Pulmonary Embolism

2d agoYahoo Finance

WATCHMAN FLX Device Clinical Trial Achieves Success

2d agoYahoo Finance

Boston Scientific's EKOS Device Shows Positive Clinical Trial Results

2d agoPRnewswire